The prevalence of COVID-19-associated diabetes is not the result of a single event but of a combination of disease susceptibility associated with chronic illness and COVID-19-specific …
Infection-related diabetes can arise as a result of virus-associated β-cell destruction. Clinical data suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly evolving worldwide and is now face-to …
L Marchand, M Pecquet, C Luyton - Acta diabetologica, 2020 - Springer
The epidemic of coronavirus disease-2019 (COVID-19) is caused by the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus. Some data describing …
S Dispinseri, V Lampasona, M Secchi… - The Journal of …, 2021 - academic.oup.com
Context Demonstrating the ability to mount a neutralizing antibody response to SARS-CoV-2 in the presence of diabetes is crucial to understand COVID-19 pathogenesis, reinfection …
We agree with the conclusion by Dr. Hill and colleagues in their commentary “COVID-19 in Patients with Diabetes”, that for patients with COVID-19 infections, the presence of diabetes …
H Sasaki, A Itoh, Y Watanabe… - Journal of diabetes …, 2022 - Wiley Online Library
The vaccine for the coronavirus disease 2019 (COVID‐19) has been reported to potentially cause or worsen diabetes. A 73‐year‐old Japanese woman received two doses of Moderna …
M Yano, T Morioka, Y Natsuki, K Sasaki… - Internal …, 2022 - jstage.jst.go.jp
During the ongoing coronavirus disease 2019 (COVID-19) pandemic, it is critical to ensure the safety of COVID-19 vaccines. We herein report a 51-year-old Japanese woman who …
V Lampasona, M Secchi, M Scavini, E Bazzigaluppi… - Diabetologia, 2020 - Springer
Aims/hypothesis The aim of the study was to characterise the humoral response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with diabetes …